Mortality in patients undergoing catheter-based therapy vs. anticoagulation alone for intermediate-high risk pulmonary embolism
Frontiers in Cardiovascular Medicine · 16.03.2026 · 13
DOI: 10.3389/fcvm.2026.1792855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 16.03.2026. Verfasst von Marcus Brugger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pulmonary embolism is a common and potentially fatal medical condition. Current guidelines recommend therapeutic anticoagulation for intermediate-high risk pulmonary embolism as a first-line strategy. However, it is unclear whether these patients may benefit from interventional treatments, such as catheter-based thrombectomy or catheter-based thrombolysis, compared to anticoagulation alone regarding mortality. Our aim was to gain insight into optimal treatment strategies of intermediate-high risk PE patients and to evaluate outcomes of different management strategies with regard to all-cause mortality.
Methods
We retrospectively evaluated a total of 236 patients, 133 patients undergoing catheter-based thrombectomy or catheter-based thrombolysis (interventional group) and 103 patients receiving anticoagulation alone (conservative group) at our institution between 2003 and 2024. All patients were classified as intermediate-high risk. The primary endpoint was all-cause mortality.
Results
The overall mortality for all patients with intermediate-high risk pulmonary embolism was 12.0% at 12 months. Depending on the treatment approach, all-cause mortality after 12 months occurred in 14 of 103 patients (14.0%) in the conservative group and in 14 of 133 patients (11.0%) in the interventional group which did not significantly differ ( p = 0.150).
Discussion
In patients with acute intermediate-high risk pulmonary embolism catheter-based treatment did not show a significant reduction in mortality within 12 months compared to anticoagulation alone.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine I, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany.
- Department of Pediatrics, TUM School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany.
- DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
Zitieren
APA
Brugger, M., Schneider, A. L., Mihatsch, L., Kafka, A., Lachmann, M., Bergmann, K., Bresha, J., Ionac, I., Zimmermann, G. S., Bradaric, C., Laugwitz, K. L., Ibrahim, T., & Müller, A. M. (2026). Mortality in patients undergoing catheter-based therapy vs. anticoagulation alone for intermediate-high risk pulmonary embolism. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1792855
Vancouver
Brugger M, Schneider AL, Mihatsch L, Kafka A, Lachmann M, Bergmann K, et al. Mortality in patients undergoing catheter-based therapy vs. anticoagulation alone for intermediate-high risk pulmonary embolism. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1792855
BibTeX
@article{Brugger2026,
author = {Brugger, Marcus and Schneider, Anna-Lena and Mihatsch, Lorenz and Kafka, Andre and Lachmann, Mark and Bergmann, Katharina and Bresha, Jola and Ionac, Ioana and Zimmermann, Gregor S and Bradaric, Christian and Laugwitz, Karl-Ludwig and Ibrahim, Tareq and Müller, Arne M},
title = {Mortality in patients undergoing catheter-based therapy vs. anticoagulation alone for intermediate-high risk pulmonary embolism},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1792855}
}
EUVIMED